Stay up-to-date with the latest news and insights from Liviniti, where we offer a fresh perspective on pharmacy benefit management.
Liviniti is proud to announce that LeAnn Boyd, CEO, has been selected for the Inc. 2025 Female Founders 500, which recognizes the most dynamic women entrepreneurs in America who are leading their organizations to success.
In response to the growing interest in glucagon-like peptide-1 (GLP-1) weight-loss medications and the cost challenges employers face to offer coverage, Liviniti, a national leader in PBM innovation, has introduced a breakthrough solution to help manage the expense that comes with increased access to these high-cost but effective treatments.
Fiduciary obligations of employer-sponsored pharmacy benefit plans are front and center in the national conversation. Recent class action lawsuits allege fiduciary breaches naming some of the nation’s best-known businesses, with legal actions alleging they failed to act as fiduciaries in managing their prescription drug plans.
Liviniti has long been known as a change agent in the complex pharmacy benefits industry, committed to operating the business with an emphasis on transparency, value, choice and service. The company helps people access the prescription medications they need, working every day to help plan members afford lifechanging and lifesaving treatments.
Steven T. Boyd, EVP, will take the podium at the Informa Connect PBM Contracting Summit, December 10-11 in Chicago, offering insights into “Navigating PBM Regulatory Changes: Legislative Insights for 2025 and Beyond.” In his role at Liviniti, Steve has worked at the center of PBM transparency for more than a dozen years, advocating for the pass-through pricing model that is the foundation of the Liviniti approach.
Liviniti is pleased to announce that Michael Stevens, CFO, has been named to the 2025 Chicago Titan 100 program recognizing the city’s Top 100 CEOs and C-level executives. With 30+ years of financial experience across leading Fortune 500 companies, Mike serves as a key member of the Liviniti executive team.
Liviniti, a national leader in PBM transparency and prescription drug savings, is taking another step to help clients reduce their pharmacy plan costs with the addition of biosimilar options for Humira® (adalimumab). Beginning in 2025, Liviniti is adding four new, lower-cost biosimilar options for treatment of a variety of inflammatory and autoimmune conditions to its formularies.
In October, we celebrate pharmacists as part of American Pharmacists Month. At Liviniti, pharmacists apply their expertise in many departments, working in roles that span clinical, product, sales, operational and executive areas of the company. While many healthcare organizations are led by individuals from a business background, Liviniti is fortunate to have the best of both worlds in CEO LeAnn Boyd, who combines strong business leadership with her background as a PharmD.
In 2014, Liviniti made a commitment to future pharmacists by launching a postgraduate, year 1 (PGY1) Managed Care/PBM Residency Program. Today the program attracts applications from dozens of newly graduated pharmacists eager to expand their horizons with broad-based, PBM experience.
Liviniti, a national leader in PBM transparency and prescription drug savings, is pleased to announce the arrival of Coley Norman as the company’s SVP of Client Experience. Coley is responsible for leading a team of client services professionals to deliver best-in-class results as they work across the organization to meet each client’s unique needs.
LeAnn Boyd, CEO, joins top female executives from across the nation at the Women Leaders in Healthcare Conference, July 16 in Chicago. Taking the stage for the session, “Finding the Right Work-Life Balance,” LeAnn will share insights that help women navigate personal and professional challenges.
Liviniti is proud to announce that Steven T. Boyd, EVP and Co-founder, has been honored with the Disruptive Entrepreneur 2024 Gold Globee® Award, honoring those who challenge conventional norms, introduce pioneering ideas and revolutionize traditional practices. Steve is recognized for his unrelenting efforts to make prescription drugs more affordable and accessible.
Liviniti CEO LeAnn Boyd will participate in a May 6 panel discussion at the Self-Insurance Institute of America (SIIA) Corporate Growth Forum in Greenville, SC. The discussion titled, “Assessing, Valuing and Investing in a ($600B) Pharmacy/Medication Management Marketplace” addresses private equity’s role in pharmacy industry investment opportunities.
LeAnn Boyd, Liviniti CEO, will join national healthcare leaders in a panel discussion at the HPI Innovations Self-Funding Conference on Tuesday, April 30 in Boston. Hugh Gallagher, Senior Vice President, Leaf Health, will moderate the GLP-1 panel discussion titled: How a Side Effect Turned into a Selling Point for Pharma.
GLP-1 weight-loss drugs are top-of-mind for health insurance agents and benefits professionals in Irving TX this week at the NABIP-TX Annual Conference. On April 16, Liviniti experts will lead a discussion on Weight Management Strategies – With and Without GLP-1s, sharing effective payer strategies for managing unprecedented demand for this class of drugs.
Liviniti is excited to announce Delivery on Demand, a national prescription delivery solution that supports convenience, adherence and a fast start to medication therapy. Available to eligible Liviniti clients who choose the service as an option for their members, Delivery on Demand features a web app to request prescription delivery to the location of the member’s choice.
Bold. Visionary. Trailblazer. Liviniti is proud to announce that LeAnn Boyd, CEO and Co-founder, has been recognized by Modern Healthcare as one of its Women Leaders for 2024. LeAnn is included in an exclusive group of executive women selected for this year’s honor. Congratulations to all the women honored this year.
Liviniti, a national PBM leader in transparency and prescription drug savings, announces a new collaboration with Mindera Health to improve management of moderate-to-severe psoriasis patients. The program utilizes Mind.Px™, a dermal biomarker patch, to improve clinical outcomes while reducing biologic drug costs for self-funded employers.
Liviniti is proud to announce that LeAnn Boyd, CEO, is part of the prestigious group of 20 healthcare leaders selected to receive the MM+M 2024 Pinnacle Awards. Honorees include leaders, marketers, strategists and creators who have scaled healthcare industry heights, with years of high achievement ahead of them. Pinnacle Awards honorees will be profiled in the May print edition of MM+M and celebrated at an in-person event scheduled for May 2 in New York City.
LeAnn Boyd, Liviniti CEO, is slated to speak at the National Association of Benefits and Insurance Professionals (NABIP) Capitol Conference on February 27. Held at the Washington, D.C. Hyatt Regency on Capitol Hill, the 34th annual conference highlights healthcare issues that affect the health insurance industry and impact the roles of agents and brokers.
Long recognized as a PBM leader in transparency and prescription drug savings, Liviniti is excited to announce the addition of the Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to its network of pharmacies.
Liviniti, a pharmacy benefit manager (PBM) committed to transparent pricing, announced today that it is partnering with Noom’s enterprise unit, Noom for Work, to assist U.S. employers in the complex arena of weight management.
Congratulations to LeAnn Boyd, Liviniti CEO, named winner of a Bronze Award in the Woman of the Year, Healthcare category of the 20th annual Stevie Awards for Women in Business.
We’ve pledged to donate to two organizations that support the education of future pharmacists through scholarships and other educational opportunities.
Liviniti has launched a month-long celebration of pharmacists highlighting their role in the communities they serve.
Liviniti CEO, LeAnn Boyd, is unrelenting in challenging the pharmacy benefit industry to move toward a better model.
We are proud to be a founding member of Transparency-Rx, working to inject common sense, change and clarity into the complex PBM industry.
Our comprehensive, PGY1 Managed Care/PBM Residency Program positions pharmacists for success and future leadership roles.
Our new company name reflects the size and national scope of one of the most trusted PBM partners in the market today.
Our clinical team does what’s best for patients and what’s right for clients, making medicine more affordable for everyone.
Thought leader, Steven T. Boyd, joined industry executives for a forward-looking discussion on PBM now and in the future.